立体定向真空辅助活检诊断为高风险乳腺病变后会发生什么?一项关于诊断后管理和影像学依从性的观察性研究
该回顾性研究纳入2012年1月至2014年12月间208例经立体定向活检诊断为高风险乳腺病变的患者,评估其后续每年或每两年一次乳腺X线筛查的依从性,并与45 508例筛查正常女性比较。总体依从率与对照组相似,但未手术组依从性显著低于手术组,且未手术组中依从者更可能曾就诊乳腺外科。
要点
- 高风险病变诊断后总体年度或两年一次乳腺X线依从率与筛查正常女性无显著差异。
- 手术组年度乳腺X线依从率70.0%显著高于未手术组32.0%(OR=5.0,95%CI:2.4,10.1,P<.001)。
- 未手术组中依从者较不依从者更可能曾就诊乳腺外科(年度77.3% vs 35.7%,P=.005)。
核心结论
- 立体定向乳腺活检诊断为高风险病变未损害后续乳腺X线筛查的总体依从性,但未手术切除的患者影像学依从性和化学预防接受率显著低于手术患者,提示专科诊疗可能对优化管理很重要。
研究设计与样本
- 机构审查委员会批准、符合HIPAA的回顾性研究,纳入2012年1月至2014年12月间208例经立体定向活检诊断为高风险病变的患者,并与同期同一机构45 508例筛查乳腺X线正常的女性比较。
- 记录患者是否接受手术切除和/或随访乳腺X线,比较1年内(9-18个月)或2年内(9-30个月)乳腺X线依从性,并评估与诊断后管理和筛查依从性可能相关的因素。
- 通过查阅临床记录确认乳腺外科会诊,评估诊断后药物化学预防的接受情况(患者决定服用化学预防药物)。
- 采用Fisher精确检验比较年度或两年一次筛查依从率,采用二元逻辑回归识别女性在选定时间范围内返回筛查的预测因素。
诊断标准与关键数值
- 67 874例女性中913例(1.3%)被建议行立体定向活检,其中208例(22.8%)诊断为高风险病变。
- 排除既往乳腺癌个人史或手术升级为癌者后,186例中124例(66.7%)接受手术,62例(33.3%)未接受手术。
- 高风险诊断后总体年度乳腺X线依从率56.4% vs 对照组50.8%(P=.160),两年一次依从率62.0% vs 60.1%(P=.630)。
- 手术组年度乳腺X线依从率70.0% vs 未手术组32.0%(OR=5.0;95%CI:2.4,10.1;P<.001),两年一次依从率74.3% vs 40.0%(OR=4.3;95%CI:2.1,8.8;P<.001)。
- 未手术组中,依从年度乳腺X线者就诊乳腺外科比例77.3% vs 不依从者35.7%(P=.005),依从两年一次者67.9% vs 不依从者36.4%(P=.045);所有接受化学预防药物的患者均行外科会诊(100%;n=21)。
临床应用与阅片要点
- 原文结论提示,专科诊疗可能对优化高风险乳腺病变患者的管理很重要。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To assess adherence with annual or biennial screening mammography after a diagnosis of high-risk lesion(s) at stereotactic biopsy with or without surgical excision and to identify clinical factors that may affect screening adherence after a high-risk diagnosis. Materials and Methods This institutional review board-approved HIPAA-compliant retrospective study included 208 patients who underwent stereotactic biopsy between January 2012 and December 2014 that revealed a high-risk lesion. Whether the patient underwent surgical excision and/or follow-up mammography was documented. Adherence of these women to a protocol of subsequent mammography within 1 year (9-18 months) or within 2 years (9-30 months) was compared with that of 45 508 women with normal screening mammograms who were imaged during the same time period at the same institution. Possible factors relevant to postdiagnosis management and screening adherence were assessed. Consultation with a breast surgeon was identified by reviewing clinical notes. Uptake of pharmacologic chemoprevention following diagnosis (patient decision to take chemopreventive medications) was assessed. The Fisher exact test was used to compare annual or biennial screening adherence rates. Binary logistic regression was used to identify factors predictive of whether women returned for screening within selected time frames. Results In total, 913 (1.3%) of 67 874 women were given a recommendation to undergo stereotactic biopsy, resulting in diagnosis of 208 (22.8%) of 913 high-risk lesions. Excluding those with a prior personal history of breast cancer or upgrade to cancer at surgery, 124 (66.7%) of 186 women underwent surgery and 62 (33.3%) did not. Overall post-high-risk diagnosis adherence to annual or biennial mammography was similar to that in control subjects (annual, 56.4% vs 50.8%, P = .160; biennial, 62.0% vs 60.1%, P = .630). Adherence was significantly better in the surgical group than in the nonsurgical group for annual mammography (70.0% vs 32.0%; odds ratio [OR] = 5.0; 95% confidence interval [CI]: 2.4, 10.1; P < .001) and for biennial mammography (74.3% vs 40.0%; OR = 4.3; 95% CI: 2.1, 8.8; P < .001). Among the patients in the nonsurgical group, those adherent to annual or biennial mammography were significantly more likely to have seen a breast surgeon than the nonadherent women (annual, 77.3% vs 35.7%, P = .005; biennial, 67.9% vs 36.4%, P = .045). All patients receiving chemopreventive agents underwent a surgical consultation (100%; n = 21). Conclusion Although diagnosis of a high-risk lesion at stereotactic breast biopsy did not compromise overall adherence to subsequent mammographic screening, patients without surgical excision, particularly those who did not undergo a surgical consultation, had significantly lower imaging adherence and chemoprevention uptake as compared with their counterparts who underwent surgery, suggesting that specialist care may be important in optimizing management. © RSNA, 2018.
引用
- Gao Y, Albert M, Young Lin LL, et al. What Happens after a Diagnosis of High-Risk Breast Lesion at Stereotactic Vacuum-assisted Biopsy? An Observational Study of Postdiagnosis Management and Imaging Adherence. Radiology. 2018. PMID: 29378151. doi:10.1148/radiol.2017171665
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。